Möchten Sie immer auf dem neuesten Stand bleiben?

Lighthouse Autism Center is Opening in Rocky Mount, North Carolina in June 2026

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204

Lighthouse Autism Center is Opening in Asheboro, North Carolina this August

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

Peer-reviewed publication validates the potential of Itay&Beyond's human CNS platform for advanced disease stratification, translational research, and R&D

New York, March 05, 2026 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Helping Children With Autism Tune Into Voices” on Tuesday,...

MCLEAN, Va., March 04, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) is proud to announce its adoption of the Higher Logic platform to power community engagement...

MENLO PARK, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- SPARK NS today announced the nine projects and principal investigators selected for the SPARK NS Translational Research Program, 2026 Cohort....

LEESBURG, Va., Feb. 05, 2026 (GLOBE NEWSWIRE) -- The Thought Leadership & Innovation Foundation (TLI) today announced that its Founder and President, Bill Oldham, has been appointed to the NIH...

Verbal Beginnings, a leading provider of comprehensive autism services, is pleased to announce the opening of a new Early Intervention center in Chantilly.